AngioDynamics to Present at the Canaccord Genuity Growth Conference

Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) announced that Executive Vice President and CFO, Stephen Trowbridge, will present at the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, at 2:00 p.m. ET. Investors can access a live webcast of the presentation on AngioDynamics' website, with a replay available afterward. The company focuses on innovative medical technologies aimed at restoring blood flow, enhancing cancer treatment options, and improving patient quality of life. More information is available at www.angiodynamics.com.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity 42^nd Annual Growth Conference at 2:00 p.m. ET on Wednesday, August 10, 2022.

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220803005837/en/

Investors:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

What is AngioDynamics' stock symbol?

AngioDynamics' stock symbol is ANGO.

When will AngioDynamics present at the Canaccord Genuity Growth Conference?

AngioDynamics will present at the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, at 2:00 p.m. ET.

Who is presenting for AngioDynamics at the conference?

Stephen Trowbridge, Executive Vice President and CFO, will present for AngioDynamics.

How can I access the AngioDynamics conference presentation?

The presentation can be accessed via a live webcast on AngioDynamics' website, with a replay available afterward.

What are AngioDynamics' primary focuses as a company?

AngioDynamics focuses on restoring healthy blood flow, expanding cancer treatment options, and improving patient quality of life.